Continuous infusion 5-fluorouracil (5FU) as a novel treatment for heavily pretreated prostate cancer patients: An update.

被引：4
|
作者：
Manogue, Charlotte
Cotogno, Patrick
Moses, Marcus Marie
Barata, Pedro C.
Layton, Jodi Lyn
Sartor, A. Oliver
Lewis, Brian E.
机构：
[1] Tulane Univ, Ctr Canc, New Orleans, LA 70118 USA
[2] Tulane Canc Ctr, Off Clin Res, New Orleans, LA USA
[3] Tulane Univ, New Orleans, LA 70118 USA
[4] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[5] Tulane Med Sch, New Orleans, LA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.319
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
319
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Adjuvant therapy (AT) with raltitrexed (RAL) in colorectal cancer (CRC) patients (pts) intolerant of 5-fluorouracil (5FU).
    Wilson, K. S.
    Barnett, J. B.
    Gill, S.
    Khoo, K. E.
    Fitzgerald, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 163S - 163S
  • [42] ARTERIAL INFUSION OF 5-FLUOROURACIL AS A TREATMENT FOR CARCINOMA OF PROSTATE
    NEVIN, JE
    MELNICK, I
    BAGGERLY, JT
    ESTEVEZ, J
    LANDES, R
    EASLEY, CA
    JOURNAL OF UROLOGY, 1974, 112 (01): : 114 - 119
  • [43] Treatment of palmoplantar keratoderma with continuous infusion 5-fluorouracil
    Lienemann, AO
    Colucci, VJ
    Jones, MS
    Trauscht, JM
    CUTIS, 2004, 73 (05): : 303 - 308
  • [44] TREATMENT OF ADVANCED CARCINOMA OF PROSTATE WITH ESTRAMUSTINE AND 5-FLUOROURACIL(FU)
    KENNEALEY, GT
    MARSH, JC
    WELCH, DA
    IAMKIS, MD
    GILL, GM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 394 - 394
  • [45] Fluctuation in Plasma 5-Fluorouracil Concentration During Continuous 5-Fluorouracil Infusion for Colorectal Cancer
    Matsumoto, Hideo
    Okumura, Hideo
    Murakami, Haruaki
    Kubota, Hisako
    Higashida, Masaharu
    Tsuruta, Atsushi
    Tohyama, Kaoru
    Hirai, Toshihiro
    ANTICANCER RESEARCH, 2015, 35 (11) : 6193 - 6199
  • [46] Does the dose of leucovorin (LV) matter with 5-fluorouracil (5FU) in colorectal cancer (CRC)?
    Biagi, James Joseph
    Coakley, Nadia
    Earle, Craig
    Erlichman, Charles
    Fields, Anthony L. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [47] The mismatch repair (MMR) complex hMutSα recognizes 5-fluorouracil (5FU) modified DNA:: a mechanism for 5FU sensitivity
    Tajima, A
    Cabrera, BL
    McMahon, H
    Doctolero, R
    Huang, S
    Carethers, J
    GASTROENTEROLOGY, 2003, 124 (04) : A21 - A21
  • [48] Symptomatic effects of methotrexate, 5fluorouracil and leucovorin in advanced colorectal cancer after failure of 5FU continuous infusion
    Cascinu, S
    Battelli, N
    Scartozzi, M
    Baldelli, AM
    Cellerino, R
    GI CANCER, 1998, 2 (03): : 203 - 206
  • [49] Mechanism for enhanced anti-tumor effects of 5-fluorouracil (5FU) by celecoxib in an advanced colon cancer model: Argiogenesis, or 5FU metabolisms?
    Irie, Takanobu
    Tsujii, Masahiko
    Tsuji, Shingo
    Ishii, Shuji
    Yoshio, Toshiyuki
    Shinzaki, Shinichiro
    Egawa, Satoshi
    Nishida, Tsutomu
    Kakiuchi, Yoshimi
    Yasumaru, Masakazu
    Iijima, Hideki
    Murata, Hiroaki
    Kawano, Sunao
    Hayashi, Norio
    GASTROENTEROLOGY, 2006, 130 (04) : A581 - A581
  • [50] ENZYMATIC CHANGES INDUCED BY THYMIDINE (TDR) AND 5-FLUOROURACIL (5FU) THERAPY
    SALSER, JS
    MARTIN, DS
    BALIS, ME
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 80 - 80
12345